Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-20-000130
Filing Date
2020-02-13
Accepted
2020-02-13 10:04:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13G zafgen13ga1-123119.htm SC 13G/A 79729
  Complete submission text file 0001013594-20-000130.txt   81313
Mailing Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108
Business Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108 617-622-4003
ZAFGEN, INC. (Subject) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88225 | Film No.: 20607458
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019 (212) 554-2379
683 Capital Management, LLC (Filed by) CIK: 0001404574 (see all company filings)

EIN.: 205100992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A